Tempe, AZ, United States of America

Lydia Meador

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Arizona State University. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lydia Meador. Retrieved from https://idiyas.com/inventor/lydia-meador

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lydia Meador: Innovator in HIV Vaccination Research

Introduction

Lydia Meador is a prominent inventor based in Tempe, AZ (US). She has made significant contributions to the field of immunology, particularly in the development of HIV vaccination compositions. Her work focuses on generating immune responses against the human immunodeficiency virus (HIV).

Latest Patents

Lydia Meador holds 1 patent for her innovative work titled "HIV vaccination compositions comprising vaccinia VLPS and plant-produced VLPS presenting HIV antigens." This patent discloses compositions designed to elicit an immune response against HIV, along with methods for their use.

Career Highlights

Lydia is affiliated with Arizona State University, where she continues her research and development in the field of vaccines. Her academic and professional journey reflects her dedication to advancing medical science and improving public health.

Collaborations

Throughout her career, Lydia has collaborated with notable colleagues, including Tsafrir S Leket-mor and Bertram L Jacobs. These partnerships have enhanced her research efforts and contributed to the advancement of HIV vaccine development.

Conclusion

Lydia Meador's innovative work in HIV vaccination research exemplifies her commitment to addressing critical health challenges. Her contributions are paving the way for future advancements in immunology and vaccine development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…